QoL questionnaire predicts nocturia, risk for falling

NewsGuard 100/100 Score

A study of Japanese outpatients highlights the association between nighttime voiding and bone fractures, after showing that the Nocturia Quality-of-Life (N-QoL) questionnaire can identify patients at risk for both.

The research team, led by Tomonori Yamanishi (Dokkyo Medical University, Mibu, Japan), received questionnaire responses, including the N-QoL, overactive bladder symptom score, and information on nighttime symptoms and falling, from 2494 patients with a mean age of 63.2 years.

Overall, 25.1% had symptoms of overactive bladder and 70.4% reported waking during the night to urinate. The mean N-QoL score was 86.8 out of 100 and 63% of patients had a score greater than 90.

The authors found that N-QoL score was significantly lower in patients with comorbid conditions, in men, and in those who complained of awakening from sleep. N-QoL score also inversely correlated with the frequency of nighttime voiding, nighttime incontinence, and nighttime falling as a result of voiding.

The researchers calculated that an N-QoL cutoff value of 90 or less had 63.1% sensitivity and 78.6% specificity for predicting night-time voiding frequency of more than twice per night, while a cutoff of 80 or less had 70.2% sensitivity and 79.5% specificity for at least one fall in a year.

“Thus, a N-QOL score ≤80 could be a criterion for selecting patients who might require additional care to prevent possible bone fracture caused by falling,” comment the authors, adding that a cutoff value of 90 may identify those patients with bothersome symptoms.

Yamanishi and colleagues say that theirs is the first validation of the Japanese N-QoL in a cross-sectional survey of outpatients from various departments. Given that at least 90% of patients were not recruited from the urology department, they say their finding that 70% reported night-time waking to void is noteworthy.

They write in the International Journal of Urology: “We conclude that the N-QOL could be a useful tool for evaluating the influence of nocturia on daily life and for examining therapeutic effects on the risk of bone fracture as a result of nocturia.”

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microfluidic chips advance neurodegenerative disease research